These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3142725)

  • 1. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
    Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
    Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bulk production and comparison of promastigote and amastigote antigens of Leishmania donovani for serodiagnosis and value of serum protein and immunoglobulin changes in diagnosis of kala-azar cases.
    Dutta GD; Dutta GP
    J Commun Dis; 1985; 17(1 Suppl):77-82. PubMed ID: 3831071
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
    Salotra P; Raina A; Negi NS
    Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of circulating antigens by McAb-AST for evaluation of the therapeutic effect of kala-azar cases].
    Hu XS; Lin FQ; Liu Q; Wang YJ; Luo P; Qin Z; Bao L; Yuan HS; Lan L
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Sep; 17(3):161-4. PubMed ID: 3557420
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of leishmania antigen in kala azar patients using monoclonal antibodies.
    Sinha R; Arora SK; Datta U; Sehgal S
    Microbiol Immunol; 1992; 36(4):391-400. PubMed ID: 1406366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of monoclonal antibodies against Leishmania donovani, II. Detection of circulating antigen in sera of visceral leishmaniasis before and after treatment].
    Qu JQ; Xu YX; Bao YF; Yang YT; Wang JY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(1):21-3. PubMed ID: 2065447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detecting L. donovani circulating antigen by McAb in the diagnosis of kala-azar].
    Hu XS; Lin FQ; Yi TL; Luo P; Wang YJ; Qin Z; Liu Q; Chai JJ
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Mar; 17(1):1-4. PubMed ID: 3804301
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunodiagnosis of Kala-azar by ELISA using intact promastigote.
    Mittal V; Sehgal S; Singh VK
    J Commun Dis; 1988 Dec; 20(4):321-6. PubMed ID: 3268597
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of antibody responses in Indian kala-azar by immunoblot.
    Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
    Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania donovani donovani and Leishmania donovani chagasi as antigens in a direct agglutination assay for the diagnosis of kala-azar.
    Andrade CR; Nascimento AE; Moura PM; Andrade PP
    Braz J Med Biol Res; 1989; 22(5):611-5. PubMed ID: 2620171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Easy test for visceral Leishmaniasis and post-Kala-azar Dermal Leishmaniasis.
    Saha S; Goswami R; Pramanik N; Guha SK; Saha B; Rahman M; Mallick S; Modak D; Silva FO; Mendonca IL; Costa DL; Costa CH; Ali N
    Emerg Infect Dis; 2011 Jul; 17(7):1304-6. PubMed ID: 21762596
    [No Abstract]   [Full Text] [Related]  

  • 16. An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar.
    Choudhry A; Puri A; Guru PY; Saxena RP; Saxena KC
    J Commun Dis; 1992 Mar; 24(1):32-6. PubMed ID: 1296950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunodiagnostic findings in patients with kala-azar].
    Mannweiler E; Lederer I; Feldmeier H
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of monoclonal antibodies to assay for circulating antigen in visceral leishmaniasis.
    Evans T
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():471-5. PubMed ID: 3253509
    [No Abstract]   [Full Text] [Related]  

  • 20. [Visceral leishmaniasis contracted in Europe (kala-azar)].
    Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W
    Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.